Bestatin potentiates the antinociception but not the motor dysfunction induced by intracerebrally administered dynorphin-B in mice

Neuropeptides. 1989 May-Jun;13(4):277-83. doi: 10.1016/0143-4179(89)90082-6.

Abstract

The intracerebrally administered dynorphin-B produced not only an antinociceptive response but a motor dysfunction such as "barrel-rolling", circling, jumping or ataxia in mice. These two effects were observed in a same dose range. Both responses were also produced by a nonopioid fragment, des-Tyr-dynorphin-B. Bestatin, an aminopeptidase inhibitor, markedly potentiated the antinociceptive response induced by dynorphin-B but not the motor dysfunction. Bestatin did not affect the responses produced by des-Tyr-dynorphin-B. In the presence of bestatin, low doses of dynorphin-B produced an antinociceptive response without the motor dysfunction. Naloxone antagonized the potentiated antinocicpetion but had no effect on the motor dysfunction. These results suggest that dynorphin-B produced an analgesia through opioid receptors and that this peptide also induced a motor dysfunction through a nonopioid receptor.

MeSH terms

  • Aminopeptidases / antagonists & inhibitors*
  • Analgesia*
  • Animals
  • Behavior, Animal / drug effects
  • Brain / drug effects*
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Dynorphins / administration & dosage
  • Dynorphins / analogs & derivatives*
  • Dynorphins / pharmacology
  • Endorphins / administration & dosage
  • Endorphins / pharmacology*
  • Injections, Intraventricular
  • Leucine / analogs & derivatives*
  • Leucine / pharmacology
  • Male
  • Mice
  • Motor Activity / drug effects*
  • Naloxone / pharmacology
  • Reaction Time / drug effects
  • Receptors, Opioid / physiology

Substances

  • Endorphins
  • Receptors, Opioid
  • Naloxone
  • Dynorphins
  • rimorphin
  • Aminopeptidases
  • Leucine
  • ubenimex